Cellebrite DI Ltd. (NASDAQ:CLBT) is Crescent Park Management L.P.’s 2nd Largest Position

Crescent Park Management L.P. increased its holdings in shares of Cellebrite DI Ltd. (NASDAQ:CLBT) by 8.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,862,482 shares of the company’s stock after acquiring an additional 142,534 shares during the period. Cellebrite DI makes up 15.7% of Crescent Park Management L.P.’s investment portfolio, making the stock its 2nd largest holding. Crescent Park Management L.P. owned about 0.90% of Cellebrite DI worth $41,030,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. True Wind Capital Management L.P. raised its position in shares of Cellebrite DI by 18.2% in the 4th quarter. True Wind Capital Management L.P. now owns 13,861,007 shares of the company’s stock worth $305,358,000 after purchasing an additional 2,130,386 shares during the last quarter. FMR LLC lifted its stake in shares of Cellebrite DI by 136.3% in the third quarter. FMR LLC now owns 5,616,757 shares of the company’s stock worth $94,586,000 after buying an additional 3,239,307 shares in the last quarter. Pertento Partners LLP grew its holdings in shares of Cellebrite DI by 26.7% during the fourth quarter. Pertento Partners LLP now owns 2,975,374 shares of the company’s stock valued at $65,547,000 after buying an additional 626,373 shares during the last quarter. Pembroke Management LTD increased its position in shares of Cellebrite DI by 4.4% during the fourth quarter. Pembroke Management LTD now owns 1,992,432 shares of the company’s stock valued at $43,893,000 after acquiring an additional 84,087 shares in the last quarter. Finally, Principal Financial Group Inc. purchased a new position in Cellebrite DI in the 3rd quarter worth approximately $23,402,000. Hedge funds and other institutional investors own 45.88% of the company’s stock.

Cellebrite DI Stock Performance

Shares of NASDAQ:CLBT opened at $19.25 on Wednesday. The stock’s 50-day simple moving average is $20.71 and its two-hundred day simple moving average is $19.94. The stock has a market capitalization of $4.61 billion, a price-to-earnings ratio of -13.85, a PEG ratio of 4.27 and a beta of 1.52. Cellebrite DI Ltd. has a 52-week low of $10.25 and a 52-week high of $26.30.

Cellebrite DI (NASDAQ:CLBT) last posted its quarterly earnings data on Thursday, February 13th. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.03). Cellebrite DI had a positive return on equity of 58.70% and a negative net margin of 70.54%. As a group, equities analysts forecast that Cellebrite DI Ltd. will post 0.3 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

CLBT has been the topic of several recent analyst reports. JPMorgan Chase & Co. increased their target price on Cellebrite DI from $24.00 to $28.00 and gave the company an “overweight” rating in a research note on Tuesday, February 11th. Lake Street Capital lifted their price objective on Cellebrite DI from $17.00 to $26.00 and gave the stock a “buy” rating in a report on Friday, February 14th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $28.00 target price on shares of Cellebrite DI in a research report on Thursday, March 27th. Seven analysts have rated the stock with a buy rating, According to data from MarketBeat, Cellebrite DI presently has a consensus rating of “Buy” and an average target price of $23.43.

Cellebrite DI Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.